Octreotide Acetate (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Octreotide Acetate drug offered from Mylan Institutional LLC. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: octreotide acetate
SUBSTANCE NAME: OCTREOTIDE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-04-01
END MARKETING DATE: 0000-00-00


Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOctreotide Acetate from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/mL)
START MARKETING DATE: 2011-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-239_8ef08ff0-1497-4734-ae76-f3a2ca7fdcd9
PRODUCT NDC: 67457-239
APPLICATION NUMBER: ANDA079198

Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCOctreotide
Mylan Institutional LLCOctreotide Acetate
Novartis Pharmaceuticals CorporationSandostatin
Sagent PharmaceuticalsOctreotide Acetate
Sandoz IncOctreotide Acetate
Teva Parenteral Medicines, Inc.Octreotide Acetate
West-Ward Pharmaceuticals Corp.Octreotide Acetate
Wockhardt LimitedOctreotide acetate
Wockhardt USA LLC.Octreotide acetate